About Prof. Mary Cahill
Prof Cahill has worked with CUH since 2004. She has a major interest in teaching medical and science students in UCC. She combines her full time clinical post with ongoing collaborative research, now focusing on autophagy in leukaemia with her colleague Dr Sharon McKenna in CCRC. In May 2017, Prof Cahill was appointed Interim Director of the CCRC.
Theme / Team
Leukaemia, Clinical Trials
Mary Cahill graduated from UCC in 1986. Having completed two years training in CUH she took up a training post in haematology in Leicester and then in the Royal London. During her time in London she completed two years of full time research on platelets and platelet function in myeloproliferative disorders, culminating in an MD award from the University of London.
She left London in 1997 to become the first (and only) Consultant Haematologist in the Mid Western Health Board providing service to Nenagh, Ennis and St John’s hospitals as well as the Mid Western Regional Hospital (now University Hospital Limerick-UHL). She gained funding from the HRB for the clinical trials unit in UHL.
She moved to CUH in 2004 where she continued her interest in clinical trials. She has a major interest in teaching medical and science students in UCC. She combines her full time clinical post with ongoing collaborative research, now focusing on autophagy in leukaemia with her colleague Dr Sharon McKenna in CCRC. Drs Cahill and McKenna have co-supervised two medical doctors carrying out research and both are likely to be future clinician scientist leaders in haematology in the future. The CCRC aims to promote patient care through research and especially through fostering clinicians who are research active using links with the core CCRC scientific staff.
She also has complimentary research interests in health care delivery and diagnosis. Currently she is involved in a large study on the diagnosis of pre-myeloma and myeloma in collaboration with Epidemiology and Public Health in UCC, thereby providing further links between CCRC and other UCC Departments.
CCRC and the department of Haematology, in which Mary has recently become a clinical Professor (2014) have strong links with Prof Caitriona O’Driscoll in the School of Pharmacy, facilitating further outreach for CCRC and fostering joint research on novel methods of therapeutics involving siRNA in leukaemia cells.
In 2015, she was awarded a SFI/ICS grant, in collaboration with colleagues in NUIG and TCD, to establish an all Ireland phase one clinical trials network firmly rooted in National Cancer Registry enhanced data collection and with additional funded enhanced bio-banking for blood cancers. This initiative, will allow for further blood cancer related research to be rooted in CCRC with enhanced opportunities for national collaboration with NUIG and TCD.
In May 2017, Prof Cahill was appointed Interim Director of the CCRC.